BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ang SY, Hutchinson DS, Patil N, Evans BA, Bathgate RAD, Halls ML, Hossain MA, Summers RJ, Kocan M. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor. Br J Pharmacol 2017;174:1077-89. [PMID: 27243554 DOI: 10.1111/bph.13522] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Pustovit RV, Zhang X, Liew JJ, Praveen P, Liu M, Koo A, Oparija-Rogenmozere L, Ou Q, Kocan M, Nie S, Bathgate RA, Furness JB, Hossain MA. A Novel Antagonist Peptide Reveals a Physiological Role of Insulin-Like Peptide 5 in Control of Colorectal Function. ACS Pharmacol Transl Sci 2021;4:1665-74. [PMID: 34661082 DOI: 10.1021/acsptsci.1c00171] [Reference Citation Analysis]
2 Lin L, Lin G, Zhou Q, Bathgate RAD, Gong GQ, Yang D, Liu Q, Wang MW. Design, synthesis and pharmacological evaluation of tricyclic derivatives as selective RXFP4 agonists. Bioorg Chem 2021;110:104782. [PMID: 33730669 DOI: 10.1016/j.bioorg.2021.104782] [Reference Citation Analysis]
3 Rovella V, Rodia G, Di Daniele F, Cardillo C, Campia U, Noce A, Candi E, Della-Morte D, Tesauro M. Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity. Nutrients 2021;13:613. [PMID: 33668627 DOI: 10.3390/nu13020613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vahkal B, Yegorov S, Onyilagha C, Donner J, Reddick D, Shrivastav A, Uzonna J, Good SV. Immune System Effects of Insulin-Like Peptide 5 in a Mouse Model. Front Endocrinol (Lausanne) 2020;11:610672. [PMID: 33519716 DOI: 10.3389/fendo.2020.610672] [Reference Citation Analysis]
5 Lin GY, Lin L, Cai XQ, Dai AT, Zhu Y, Li J, Liu Q, Yang DH, Bathgate RAD, Wang MW. High-throughput screening campaign identifies a small molecule agonist of the relaxin family peptide receptor 4. Acta Pharmacol Sin 2020;41:1328-36. [PMID: 32235863 DOI: 10.1038/s41401-020-0390-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li SB, Liu YY, Yuan L, Ji MF, Zhang A, Li HY, Tang LQ, Fang SG, Zhang H, Xing S, Li MZ, Zhong Q, Lin SJ, Liu WL, Huang P, Zeng YX, Zheng YM, Ling ZQ, Sui JH, Zeng MS. Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling. EMBO Mol Med 2020;12:e12050. [PMID: 32657028 DOI: 10.15252/emmm.202012050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ang SY, Evans BA, Poole DP, Bron R, DiCello JJ, Bathgate RAD, Kocan M, Hutchinson DS, Summers RJ. INSL5 activates multiple signalling pathways and regulates GLP-1 secretion in NCI-H716 cells. J Mol Endocrinol 2018;60:213-24. [PMID: 29535183 DOI: 10.1530/JME-17-0152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
8 Alnafea H, Vahkal B, Zelmer CK, Yegorov S, Bogerd J, Good SV. Japanese medaka as a model for studying the relaxin family genes involved in neuroendocrine regulation: Insights from the expression of fish-specific rln3 and insl5 and rxfp3/4-type receptor paralogues. Mol Cell Endocrinol 2019;487:2-11. [PMID: 30703485 DOI: 10.1016/j.mce.2019.01.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hecker N, Sharma V, Hiller M. Convergent gene losses illuminate metabolic and physiological changes in herbivores and carnivores. Proc Natl Acad Sci U S A 2019;116:3036-41. [PMID: 30718421 DOI: 10.1073/pnas.1818504116] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 12.3] [Reference Citation Analysis]
10 Sun EWL, Martin AM, Young RL, Keating DJ. The Regulation of Peripheral Metabolism by Gut-Derived Hormones. Front Endocrinol (Lausanne) 2018;9:754. [PMID: 30662430 DOI: 10.3389/fendo.2018.00754] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
11 Valkovic AL, Leckey MB, Whitehead AR, Hossain MA, Inoue A, Kocan M, Bathgate RAD. Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor. Pharmacol Res Perspect 2018;6:e00432. [PMID: 30263124 DOI: 10.1002/prp2.432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Adriaenssens AE, Reimann F, Gribble FM. Distribution and Stimulus Secretion Coupling of Enteroendocrine Cells along the Intestinal Tract. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1603-38. [DOI: 10.1002/cphy.c170047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
13 Bathgate RA, Kocan M, Scott DJ, Hossain MA, Good SV, Yegorov S, Bogerd J, Gooley PR. The relaxin receptor as a therapeutic target – perspectives from evolution and drug targeting. Pharmacology & Therapeutics 2018;187:114-32. [DOI: 10.1016/j.pharmthera.2018.02.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
14 Zaykov AN, Gelfanov VM, Liu F, Dimarchi RD. Synthesis and Characterization of the R27S Genetic Variant of Insulin-like Peptide 5. ChemMedChem 2018;13:852-9. [DOI: 10.1002/cmdc.201800057] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Summers RJ. Recent progress in the understanding of relaxin family peptides and their receptors. Br J Pharmacol. 2017;174:915-920. [PMID: 28447360 DOI: 10.1111/bph.13778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ang SY, Hutchinson DS, Evans BA, Hossain MA, Patil N, Bathgate RA, Kocan M, Summers RJ. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4. Naunyn Schmiedebergs Arch Pharmacol 2017;390:105-11. [PMID: 27888281 DOI: 10.1007/s00210-016-1321-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
17 Ang SY, Hutchinson DS, Patil N, Evans BA, Bathgate RAD, Halls ML, Hossain MA, Summers RJ, Kocan M. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor. Br J Pharmacol 2017;174:1077-89. [PMID: 27243554 DOI: 10.1111/bph.13522] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]